This project is designed to increase our understanding of cancer cell biology and to develop a new approach to cancer treatment through the study of growth-regulatory signal transduction events. This work is currently focused on (1) novel aspects of the regulation of cancer cell growth by the retinoblastoma susceptibility gene family and (2) the molecular mechanism of negative growth regulation by cyclic AMP. The retinoblastoma protein is currently thought to function only in the cell nucleus and only in the G1 phase of the cell cycle. In contrast, using confocal microscopy and co-immunoprecipitation techniques we found that Rb is associated with the cell cytoskeleton and that this localization is regulated as a function of the cell cycle. These data were supported by in vitro transcription-translation experiments using wild type and mutant GST-Rb constructs, and by transient transfections using hemagglutinin-tagged wild type and mutant Rb constructs. These data suggest a new model of tumor suppressor gene function, in which the tumor suppressor gene product is responsive to cell-cell or cell-substratum interactions. While studying the anticancer action of cyclic AMP we determined that elevation of intracellular cyclic AMP causes loss of cyclin A expression and down-regulation of cyclin A-regulated cyclin-dependent kinase activity. Our recent studies on the mechanism of cyclic AMP-induced G1 arrest in prostate cancer cells demonstrate that cyclic AMP induces transcription of the cyclin-dependent kinase inhibitor p21. We are mapping the cyclic AMP-responsive element on the p21 promoter and have begun characterizing the factors activating the proximal promoter in response to cyclic AMP. These studies demonstrate that cAMP activates the p21 promoter through a novel, non-CRE-mediated mechanism. Furthermore, the data demonstrate the role of histone acetylases (HATs) in p21 promoter activation in response to cAMP.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006743-07
Application #
6433123
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Pise-Masison, Cynthia A; Radonovich, Michael; Dohoney, Kathleen et al. (2009) Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood 113:4016-26
Mushinski, J Frederic; Nguyen, Phuongmai; Stevens, Lisa M et al. (2009) Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem 284:15206-14
Kajiguchi, T; Chung, E J; Lee, S et al. (2007) FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Leukemia 21:2476-84
Giubellino, Alessio; Gao, Yang; Lee, Sunmin et al. (2007) Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist. Cancer Res 67:6012-6
Xu, W; Soga, S; Beebe, K et al. (2007) Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition. Br J Cancer 97:741-4
Gojo, Ivana; Jiemjit, Anchalee; Trepel, Jane B et al. (2007) Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood 109:2781-90
Niedermeier, Andrea; Talanin, Nickolai; Chung, Eun Joo et al. (2006) Histone Deacetylase Inhibitors Induce Apoptosis with Minimal Viral Reactivation in Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus. J Invest Dermatol 126:2516-24
Athauda, Gagani; Giubellino, Alessio; Coleman, Jonathan A et al. (2006) c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res 12:4154-62
Marcu, Monica G; Jung, Yun-Jin; Lee, Sunmin et al. (2006) Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2:169-74
Chung, Eun Joo; Lee, Min-Jung; Lee, Sunmin et al. (2006) Assays for pharmacodynamic analysis of histone deacetylase inhibitors. Expert Opin Drug Metab Toxicol 2:213-30

Showing the most recent 10 out of 29 publications